Case 14-2004: A 66-year-old man with progressive neurologic deficits

New England Journal of Medicine

Volumn 350, Issue 18, 2004, Pages 1882-1893

  Koralnik, Igor J ^a,c   Schellingerhout, Dawid ^b,c   Frosch, Matthew P ^b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRAIN BIOPSY; BRAIN CANCER; BRAIN INFARCTION; CASE REPORT; CLINICAL FEATURE; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JC VIRUS; LABORATORY TEST; LEUKOENCEPHALOPATHY; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; VIRUS INFECTION; ALCOHOL LIVER CIRRHOSIS; BIOPSY; BRAIN; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; FATALITY; KIDNEY TRANSPLANTATION; PARESIS; PATHOLOGY;

AGED; BIOPSY; BRAIN; CEREBROVASCULAR ACCIDENT; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LIVER CIRRHOSIS, ALCOHOLIC; MAGNETIC RESONANCE IMAGING; MALE; PARESIS;

EID: 2342581471     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcpc030038     Document Type: Article

References (34)

1. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab 1996;16: 53-9.
2. Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 2000;69:467-72.
3. Berger JR, Sheremata WA, Resnick L, Atherton S, Fletcher MA, Norenberg M. Multiple sclerosis-like illness occurring with human immunodeficiency virus infection. Neurology 1989;39:324-9.
4. Phan TG, O'Neill BP, Kurtin PJ. Post-transplant primary CNS lymphoma. Neurooncology 2000;2:229-38.
5. Cinque P, Vago L, Dahl H, et al. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 1996;10:951-8.
6. Antinori, Ammassari A, De Luca A, et al. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 1997;48:687-94.
7. Moussouttas M. Intravascular lymphomatosis presenting as posterior leukoencephalopathy. Arch Neurol 2002;59:640-1.
8. Tateishi U, Terae S, Ogata A, et al. MR imaging of the brain in lymphomatoid granulomatosis. AJNR, Am J Neuroradiol 2001; 22:1283-90.
9. Herrlinger U, Felsberg J, Kulcer W, et al. Gliomatosis cerebri: molecular pathology and clinical course. Ann Neurol 2002;52: 390-9.
10. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000;342:635-45. [Erratum, N Engl J Med 2000;342:1063.]
11. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000;342:635-45. [Erratum, N Engl J Med 2000;342:1063.]
12. Post MJ, Tate LG, Quencer RM, et al. CT, MR, and pathology in HIV encephalitis and meningitis. AJR, Am J Roentgenol 1988;151: 373-80.
13. Langford TD, Letendre SL, Marcotte TD, et al. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 2002;16:1019-29.
14. Hallervorden J. Eigerartige und nicht rubrizierbare Prozesse. In: Bumke O, ed. Handbuch der Geiteskrankheiten. Vol. 2. Berlin: Springer, 1930:1063-107.
15. Astrom KE, Mancall EL, Richardson EP Jr. Progressive multifocal leukoencephalopathy: a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958;81:93-127.
16. ZuRhein GM, Chou S-M. Particles resembling papova viruses in human cerebral demyelinating disease. Science 1965; 148:1477-9.
17. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971;1:1257-60.
18. Weber T, Trebst C, Frye S, et al. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J infect Dis 1997;176: 250-4.
19. Bofill-Mas S, Girones R. Excretion and transmission of JCV in human populations. J Neurovirol 2001;7:345-9.
20. Power C, Gladden JG, Halliday W, et al. AIDS- and non-AIDS-related PML association with distinct p53 polymorphism. Neurology 2000;54:743-6.
21. Manz HJ, Dinsdale HB, Morrin PA. Progressive multifocal leukoencephalopathy after renal transplantation: demonstration of papova-like virions. Ann Intern Med 1971; 75:77-81.
22. Berner B, Krieter DH, Rumpf KW, et al. Progressive multifocal leukoencephalopathy in a renal transplant patient diagnosed by JCV-specific DNA amplification and an intrathecal humoral immune response to recombinant virus protein 1. Nephrol Dial Transplant 1999;14:462-5.
23. Martinez AJ, Ahdab-Barmada M. The neuropathology of liver transplantation: comparison of main complications in children and adults. Mod Pathol 1993;6:25-32.
24. Weber T, Turner RW, Frye S, et al. Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluid. AIDS 1994;8:49-57.
25. Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 1999;52: 253-60.
26. Cinque P, Koralnik IJ, Clifford DB. The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus for terminology definition. J Neurovirol 2003;9: Suppl 1:88-92.
27. Marra CM, Rajicic N, Barker DE, et al. A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 2002;16:1791-7.
28. Aksamit AJ. Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirol 2001;7:386-90.
29. Du Pasquier RA, Koralnik IJ. Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? J Neurovirol 2003;9:Suppl 1:25-31.
30. Richardson EP Jr, Johnson PC. Atypical progressive multifocal leukoencephalopathy with plasma-cell infiltrates. Acta Neuropathol (Berl) 1975;Suppl 6:247-50.
31. Berger JR, Levy RM, Flomenhoft D, Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 1998;44: 341-9.
32. Koralnik IJ, Du Pasquier RA, Kuroda MJ, et al. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol 2002;168:499-504.
33. p36 in patients with proven or possible progressive multifocal leukoencephalopathy. J Virol 2003;77: 11918-26.
34. Chang L, Ernst T, Tornatore C, et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 1997;48:836-45.